CRY - CryoLife, Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
30/12/2015
Total revenue
274,324
262,841
189,702
180,380
145,898
Cost of revenue
92,672
89,857
61,060
61,481
55,179
Gross profit
181,652
172,984
128,642
118,899
90,719
Operating expenses
Research development
24,432
23,098
19,461
13,446
10,436
Selling general and administrative
141,030
140,574
101,211
91,548
74,929
Total operating expenses
165,462
163,672
120,672
104,994
85,365
Operating income or loss
16,190
9,312
7,970
13,905
5,354
Interest expense
15,185
15,788
4,881
3,043
62
Total other income/expenses net
-3,060
-141
260
7,478
407
Income before tax
-1,362
-6,391
3,561
18,412
5,868
Income tax expense
-2,987
-2,586
-143
7,634
1,863
Income from continuing operations
1,625
-3,805
3,704
10,778
4,005
Net income
1,625
-3,805
3,704
10,778
4,005
Net income available to common shareholders
1,615
-3,805
3,704
10,570
4,005
Reported EPS
Basic
-
-0.10
0.11
0.33
0.14
Diluted
-
-0.10
0.11
0.32
0.14
Weighted average shares outstanding
Basic
-
36,412
33,008
31,855
27,744
Diluted
-
36,412
34,163
32,822
28,542
EBITDA
-
9,397
18,187
29,839
5,930